Volume : 12, Issue : 10, October – 2025

Title:

FORMULATION AND EVALUATION OF THIOCOLCHICOSIDE LOADED TRANSDERMAL PATCHES

Authors :

Fatima Aiyman, Dr. Faizan Sayeed, Dr. Abdul Sayeed, Dr. Syed Areefulla Hussainy

Abstract :

Abstract:
The present study focuses on the formulation and evaluation of Thiocolchicoside-loaded transdermal patches aimed at providing sustained drug delivery, improving therapeutic efficacy, and enhancing patient compliance. Thiocolchicoside, a centrally acting muscle relaxant with poor oral bioavailability and gastrointestinal side effects, was incorporated into matrix-type transdermal patches using various polymers such as Eudragit S 100 and Ethylcellulose along with suitable plasticizers.
The prepared patches were evaluated for their physicochemical properties including thickness, weight uniformity, folding endurance, moisture content, drug content, and surface pH. In-vitro drug release studies were conducted using Franz diffusion cells to assess the release profile of Thiocolchicoside over 12 hours. Among the various formulations, the optimized patch demonstrated satisfactory mechanical properties, high drug content uniformity, and a sustained drug release profile following like Higuchi or Korsmeyer-Peppas] kinetics.
The results suggest that transdermal delivery of Thiocolchicoside is a promising alternative to oral administration, potentially minimizing systemic side effects and improving patient adherence.
Keywords: Thiocolchicoside, transdermal patches.

Cite This Article:

Please cite this article in press Fatima Aiyman et al., Formulation And Evaluation Of Thiocolchicoside Loaded Transdermal Patches, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1. Chien Y.W., Liu J.C. Transdermal drug delivery systems. J. Biomater. Appl. 1986;1:183–206. doi: 10.1177/088532828600100202.
2. Lasagna L., Greenblatt D.J. More than skin deep: Transdermal drug-delivery systems. N. Engl. J. Med. 1986;314:1638–1639. doi: 10.1056/NEJM198606193142509.
3. Kopper N.W., Gudeman J., Thompson D.J. Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies. Drug Des. Dev. Ther. 2009;2:193–202. doi: 10.2147/DDDT.S4146.
4. Al Hanbali O.A., Khan H.M.S., Sarfraz M., Arafat M., Ijaz S., Hameed A. Transdermal patches: Design and current approaches to painless drug delivery. Acta Pharm. 2019;69:197–215. doi: 10.2478/acph-2019-0016.
5. Margetts,2007; Singh & Morris, 2011.
6. Hao et al., 2016.
7. Wokovich A.M., Prodduturi S., Doub W.H., Hussain A.S., Buhse L.F. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur. J. Pharm. Biopharm. 2006;64:1–8. doi: 10.1016/j.ejpb.2006.03.009.
8. Invernale M.A., Tang B.C., York R.L., Le L., Hou D.Y., Anderson D.G. Microneedle electrodes toward an amperometric glucose-sensing smart patch. Adv. Healthc. Mater. 2014;3:338–342. doi: 10.1002/adhm.201300142.
9. Veiseh O., Langer R. Diabetes: A smart insulin patch. Nature. 2015;524:39–40. doi: 10.1038/524039a.
10. Lee I.C., Lin W.M., Shu J.C., Tsai S.W., Chen C.H., Tsai M.T. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. J. Biomed. Mater. Res. Part A. 2017;105:84–93. doi: 10.1002/jbm.a.35869.
11. Jang M.J., Bae S.K., Jung Y.S., Kim J.C., Kim J.S., Park S.K., Suh J.S., Yi S.J., Ahn S.H., Lim J.O. Enhanced wound healing using a 3D printed VEGF-mimicking peptide incorporated hydrogel patch in a pig model. Biomed. Mater. 2021;16:045013. doi: 10.1088/1748-605X/abf1a8.
12. Caudill C., Perry J.L., Iliadis K., Tessema A.T., Lee B.J., Mecham B.S., Tian S., DeSimone J.M. Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. Proc. Natl. Acad. Sci. USA. 2021;118:e2102595118. doi: 10.1073/pnas.2102595118.
13. Yadav V., Sharma P.K., Murty U.S., Mohan N.H., Thomas R., Dwivedy S.K., Banerjee S. 3D printed hollow microneedles array using stereolithography for efficient transdermal delivery of rifampicin. Int. J. Pharm. 2021;605:120815. doi: 10.1016/j.ijpharm.2021.120815.
14. Lim S.H., Kathuria H., Amir M.H.B., Zhang X., Duong H.T.T., Ho P.C., Kang L. High resolution photopolymer for 3D printing of personalised microneedle for transdermal delivery of anti-wrinkle small peptide. J. Control. Release. 2021;329:907–918. doi: 10.1016/j.jconrel.2020.10.021.
15. Yang D., Liu C., Quan P., Fang L. Molecular mechanism of high capacity-high release transdermal drug delivery patch with carboxyl acrylate polymer: Roles of ion-ion repulsion and hydrogen bond. Int. J. Pharm. 2020;585:119376. doi: 10.1016/j.ijpharm.2020.119376.
16. Choi I.J., Cha H.R., Hwang S.J., Baek S.K., Lee J.M., Choi S.O. Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling. Pharmaceutics. 2021;13:209. doi: 10.3390/pharmaceutics13020209.
17. Sullivan S.P., Koutsonanos D.G., Del Pilar Martin M., Lee J.W., Zarnitsyn V., Choi S.O., Murthy N., Compans R.W., Skountzou I., Prausnitz M.R. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 2010;16:915–920. doi: 10.1038/nm.2182.
18. . Sugumar V., Ang K.P., Alshanon A.F., Sethi G., Yong P.V.C., Looi C.Y., Wong W.F. A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method. Pharmaceutics. 2022;14:1406. doi: 10.3390/pharmaceutics14071406.
19. Seong K.Y., Seo M.S., Hwang D.Y., O’Cearbhaill E.D., Sreenan S., Karp J.M., Yang S.Y. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin. J. Control. Release. 2017;265:48–56. doi: 10.1016/j.jconrel.2017.03.041.
20. Corbo M., Liu J.C., Chien Y.W. Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci. 1990;79:584–587. doi: 10.1002/jps.2600790707.
21. . Thakur R., Anwer M.K., Shams M.S., Ali A., Khar R.K., Shakeel F., Taha E.I. Proniosomal transdermal therapeutic system of losartan potassium: Development and pharmacokinetic evaluation. J. Drug Target. 2009;17:442–449. doi: 10.1080/10611860902963039.
22. Noonan P.K., Gonzalez M.A., Ruggirello D., Tomlinson J., Babcock-Atkinson E., Ray M., Golub A., Cohen A. Relative bioavailability of a new transdermal nitroglycerin delivery system. J. Pharm. Sci. 1986;75:688–691. doi: 10.1002/jps.2600750715.
23. Andersson T.L., Stehle B., Davidsson B., Hoglund P. Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara. Maturitas. 2000;34:57–64. doi: 10.1016/S0378-5122(99)00088-2.
24. . Raynaud J.P., Aumonier C., Gualano V., Betea D., Beckers A. Pharmacokinetic study of a new testosterone-in-adhesive matrix patch applied every 2 days to hypogonadal men. J. Steroid Biochem. Mol. Biol. 2008;109:177–184. doi: 10.1016/j.jsbmb.2008.02.004.
25. Elshoff J.P., Cawello W., Andreas J.O., Mathy F.X., Braun M. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson’s disease and restless legs syndrome. Drugs. 2015;75:487–501. doi: 10.1007/s40265-015-0377-y.
26. Ramadon D., Permana A.D., Courtenay A.J., McCrudden M.T.C., Tekko I.A., McAlister E., Anjani Q.K., Utomo E., McCarthy H.O., Donnelly R.F. Development, Evaluation, and Pharmacokinetic Assessment of Polymeric Microarray Patches for Transdermal Delivery of Vancomycin Hydrochloride. Mol. Pharm. 2020;17:3353–3368. doi: 10.1021/acs.molpharmaceut.0c00431.
27. Dara Ananthalakshmi, Etikala Sravya, Kothapalli Rakesh, Penaka Aishwarya, Singapogu Sivaparvathi, Vemula Kanaka Naga Lakshmi Prasanna and Dr. T. Satyanarayana. formulation and evaluation of transdermal patches of metoprolol succinate. World Journal of Pharmaceutical Research ,Volume 12, Issue 4, 1503-1514.
28. Chandan, S., Nishant, T., Bhupinder, K., & Manish, G. (2022). Recent advancements in transdermal patches: Literature review. International Journal of Health Sciences, 6(S1), 6443–6460.
29. Rajwant Kaur, Saahil Arora, Manish Goswami,.Formulation development and evaluation of Transdermal patch of Astaxanthin,Materials Today: Proceedings,2022,,ISSN 2214-7853,https://doi.org/10.1016/j.matpr.2022.11.119.
30. Vijendra Pal Singh Rathore; Komal Tikariya; Dr. Jayanti Mukherjee. Formulation and Evaluation of Transdermal Patch of Thiochochicoside. Int. Journal of Pharmaceutical Sciences and Medicine (IJPSM), Vol.6 Issue. 12, December- 2021, pg. 18-28.
31. Pethani, D.K., & Prajapati, S.T. (2020). Formulation Designing Factors for Development of Repaglinide Transdermal Therapeutic System. International Journal of Pharmaceutical Sciences and Drug Research.
32. Kondapuram Parameshwar, Suvendu Kumar Sahoo , Rabinarayan Parhi , Ravi Kumar V , Ahad Ahmed kodipad , Priyadharshini Selvaraj. Formulation and in-vitro evaluation of a transdermal patch loaded with letrozole. Kondapuram Parameshwar et al., Int. J. Res. Pharm. Sci., 2020, 11 (SPL4), 997-1005.
33. Gauri A. Nilewar, Prashant L. Takdhat, Shruti M. Thakre and Parag D. Bhagwatkar. Formulation And Evaluation Of Repaglinide Transdermal Patches For Treatment Of Diabetes. World Journal of Pharmaceutical Research Volume 7, Issue 17, 1342-1353. ISSN 2277– 7105.